Hansoh Pharmaceutical Group Co Ltd
03692
Company Profile
Business description
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.
Contact
287 Xiangke Road
Pudong New District
Shanghai201210
CHNSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
9,313
Stocks News & Analysis
stocks
What does big US court decision mean for Google’s parent company Alphabet?
Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.
stocks
Is this still an ASX share to own forever?
Find out how this defensive player has fared after earnings.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,140.50 | 11.00 | 0.12% |
CAC 40 | 7,674.78 | 24.14 | -0.31% |
DAX 40 | 23,596.98 | 173.35 | -0.73% |
Dow JONES (US) | 45,400.86 | 220.43 | -0.48% |
FTSE 100 | 9,208.21 | 8.66 | -0.09% |
HKSE | 25,417.98 | 359.47 | 1.43% |
NASDAQ | 21,700.39 | 7.30 | -0.03% |
Nikkei 225 | 43,018.75 | 438.48 | 1.03% |
NZX 50 Index | 13,223.53 | 90.33 | 0.69% |
S&P 500 | 6,481.50 | 20.58 | -0.32% |
S&P/ASX 200 | 8,871.20 | 8.60 | 0.10% |
SSE Composite Index | 3,812.51 | 46.64 | 1.24% |